Publicaciones en las que colabora con MANUEL PRAGA TERENTE (18)

2024

  1. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

    Kidney International, Vol. 105, Núm. 1, pp. 177-188

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  2. Thrombotic microangiopathy in patients with malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226

2022

  1. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137

  2. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  3. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

  4. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

  2. Update on C3 Glomerulopathy: A Complement-Mediated Disease

    Nephron, Vol. 144, Núm. 6, pp. 272-280

2019

  1. The role of complement in IgA nephropathy

    Molecular Immunology, Vol. 114, pp. 123-132

2018

  1. CD19+ B-cells, a new biomarker of mortality in hemodialysis patients

    Frontiers in Immunology, Vol. 9, Núm. JUN

2017

  1. Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

    Kidney International, Vol. 92, Núm. 4, pp. 953-963

  2. The presence of pretransplant antiphospholipid antibodies iga anti-b-2-glycoprotein i as a predictor of graft thrombosis after renal transplantation

    Transplantation, Vol. 101, Núm. 3, pp. 597-607

2015

  1. Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I

    Journal of the American Society of Nephrology, Vol. 26, Núm. 3, pp. 735-745

2012

  1. IgA antibodies against Β2 glycoprotein i in hemodialysis patients are an independent risk factor for mortality

    Kidney International, Vol. 81, Núm. 12, pp. 1239-1244

1997

  1. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 12, Núm. 12, pp. 2576-2579

1990

  1. SINDROME DE GOODPASTURE Y GLOMERULONEFRITIS MEMBRANOSA

    Nefrologia, Vol. 10, Núm. 1, pp. 84-89